BioCryst Pharmaceuticals, Inc. (BCRX)

8.75 +0.85 (+10.76%) USD  |  NASDAQ  |  Feb 27, 16:00
8.61 -0.14 (-1.60%) Pre-Market: 08:55
More

BioCryst Pharmaceuticals Total Expenses (Annual)

Total Expenses (Annual) Chart

View Total Expenses (Annual) for BCRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Annual) Range, Past 5 Years

View Total Expenses (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Annual) Benchmarks

View Total Expenses (Annual) Benchmarks
Start Trial
Anika Therapeutics, Inc. Upgrade
KalVista Pharmaceuticals, Inc. Upgrade
Lantheus Holdings, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
BioStem Technologies, Inc. Upgrade